Sentence examples for on biologics from inspiring English sources

"In today's market I can see four acne patients in the time I see one patient on biologics,"' said Dr. William Abramovits, a professor of dermatology at Baylor University Medical Center in Dallas, referring to the biotech psoriasis drugs, which he prescribes despite the obstacles.

In real life, approximately one-third of RA patients on biologics are on monotherapy [ 12- 14].

When asked whether the US and Australia were within striking distance of a compromise on biologics, Robb told US website Inside Trade "Yes, we are".

Japanese economy minister Akira Amari said he had agreed to a US request to stay on in Atlanta for another 24 hours, but said the US had to find a way forward on biologics.

That ramp-up is already evident: Express Scripts, a pharmacy benefits manager, says its spending on biologics grew 10percentt last year, compared with 2.5percentt for other drugs.

"The US was initially seeking 12 years of data exclusivity on biologics, and they have now backed down to eight years in this draft, which they're selling as a big concession and as a new flexibility," said Gleeson, who is also a spokeswoman for the Public Health Association of Australia.

While Campbell's concern is worthy of note, one has to think that the FDA review panel on follow-on biologics will be as careful as the original reviewing panel, and they will understand that they need to consider interchangeability.

Follow-on biologics and crude drugs are beyond the focus of this review.

The value stems not only from the drug prGCD, but in Protalix’s unique plant-cell based platform as an efficient producer of follow-on biologics.

Now the generic-drug makers, and even some specialty pharma companies, are investing in technology to bring these follow-on biologics to market, and so they are likely to become more forceful advocates for a change in the law.

For these reasons, any abbreviated pathway for approving follow-on biologics is still likely to include more testing than simply proving structural equivalence, as generic-drug companies must do when they make copies of pills.